Helping to share the future through strategy, science, creativity and data
With the surge of rare disease therapies advancing through clinical trials and nearing FDA approval, we have built a specialized commercialization agency to shepherd these products to market. Success in this space demands a unique blend of patient insights, scientific expertise, strategic planning, and creative execution. We focus on delivering personalized, empathetic communication through omnichannel digital outreach, while leveraging PR and media to build awareness and advocacy. This is our why and our how.
Our story
CG Life’s foundation is science. For over 20 years, we’ve been rooted in the discipline and rigor of translating scientific discovery into compelling brand experiences, helping innovators realize the potential of their products and therapies.
We’ve been there every step of the way, from biomedical research tools to therapeutic products navigating clinical trials. Our in-house PhDs dive deep into the science to shape stories that inspire and engage.
In early 2023, under the leadership of CEO David Ormesher and with the support of Shore Capital, our next chapter became obvious: we know genomics and cell and gene therapies for rare diseases. Now it’s time to be the agency that will support these therapies through commercial launch. But to do that, we needed to expand.
That’s why we acquired Toolhouse, a well-respected digital agency with rare disease clients and expertise in digital transformation, customer experience, and data analytics. Two months later, we acquired Berry & Co., a specialist PR and social media agency focused on early-stage biopharma.
In just three months, we combined expert capabilities in science, strategy, PR, digital, data analytics, media, and social, doubling the size of our agency.
We’re laser-focused on a few key priorities: helping our clients bring life-changing therapies to patients with rare and hard-to-treat diseases, uniting and integrating our three companies under the CG Life banner, and constantly innovating to bring new commercialization solutions to pharma.
We serve the inventors and visionaries, but we are driven by the needs of patients, caregivers, and healthcare professionals. Committed to excellence, we relentlessly pursue our mission to improve the lives of patients with rare diseases.
And we’re just getting started…
We are CG Life, and this is our story.
How has science shaped you?
Hear what science means in our CG lives—and in our collaborators’ lives as well.
David Ormesher
CEO of CG Life
Paul Song
CEO of NKGen
Lisa Sellers
CEO of Vector Labs
Jim Banks
Associate Creative Director, CG Life
Karen Langhauser
Chief Content Director of Endeavor Business Media
Susan Stipa
Executive Vice President of CG Life
Our team at a glance
Person team
Time zones
Integrated departments
20+ Year history
Our leaders
Chief Executive Officer
David Ormesher
Chief Operating Officer
Jon Sawyer
Chief Financial Officer
Scott Thompson
VP Sales
Kyle Bechter
SVP Public Relations
Bill Berry
EVP Business Development
Jay Carter
VP Public Relations
Blair Ciecko
Managing Director, Strategic Communications Group
Erik Clausen
VP Social Media
Adam Daley
VP Human Resources
Caitlin Golden
SVP Client Engagement
Sarah Harris
Director of Finance
Shahmir Jiwani
Managing Partner
Steve Johnson
VP Business Development
Todd Kuna
Executive Director, Creative
Lawrence Lee
VP Digital Strategy
Abby McCormack
SVP Client Delivery
Kari Obrist
VP Project Management
Kayla Philip
Group Director, Content
Juliet Preston
VP Client Services
Nina Prybula
VP Project Management
Adrienne Ross
SVP Public Relations
Karen Sharma
EVP Strategic Accounts
Susan Stipa
SVP Technology
Kevin Stock
Sr. Director, Paid Media
Jenine Vadillo
SVP Strategy
Chris Weber
SVP Digital
Mike Wiebe
Managing Director, Element CG
Jeremiah Worth
Better together
CG Life integrates specialty agencies and their distinct areas of focus and expertise.
Together, we help Life Science companies connect and grow.
CG Life is a fully integrated marketing and communications agency that uniquely combines science, strategy and creativity to translate our client’s technology, products or therapies into brand experiences that makes an impact in the marketplace.
Toolhouse helps leading life science companies use technology to build meaningful connections with patients and physicians. Key areas of focus include omnichannel enablement, audience engagement across digital channels, and optimizing channels with data-driven insights.
Element CG, a specialty agency complementing CG Life, builds brands for innovative, early-stage life science and biopharma companies and provides robust production services for established brands.
Berry & Company’s team of healthcare communications specialists is dedicated to helping patients, caregivers, clinicians, researchers, investors, industry partners, payers and policymakers get the information they need about medical research, products and services.